Differential diagnosis of behçet uveitis

Ocular Immunology and Inflammation

Volumn 21, Issue 5, 2013, Pages 337-350

  Tugal Tutkun, Ilknur ^a   Gupta, Vishali ^b,c   Cunningham, Emmett T ^d,e  

^a ISTANBUL UNIVERSITY   (Turkey)

^b KING KHALED EYE SPECIALIST HOSPITAL   (Saudi Arabia)

^c POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^d CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anterior uveitis; Beh et uveitis; Intermediate uveitis; Retinal vasculitis; Retinitis

Indexed keywords

HLA B27 ANTIGEN;

AMYLOIDOSIS; ANTERIOR EYE SEGMENT; ARTICLE; ASTEROID HYALITIS; AUTOIMMUNE HEPATITIS; BEHCET DISEASE; BRUCELLOSIS; CAT SCRATCH DISEASE; CATARACT; CHORIORETINITIS; CHORIORETINOPATHY; CLINICAL FEATURE; CORNEA ULCER; CYTOMEGALOVIRUS RETINITIS; DIFFERENTIAL DIAGNOSIS; DIFFUSE VITRITIS; ENDOGENOUS ENDOPHTHALMITIS; ENTERITIS; EYE INFLAMMATION; EYE INJURY; FOCAL RETINITIS; FUCHS UVEITIS SYNDROME; GLAUCOMA; HERPES SIMPLEX VIRUS; HUMAN; HYPOPYON; INTERMEDIATE UVEITIS; INTERSTITIAL NEPHRITIS; INTESTINE LIPODYSTROPHY; INTRAOCULAR FOREIGN BODY; INTRAOCULAR HEMORRHAGE; IRIDOCYCLITIS; LEUKEMIA; LYME DISEASE; LYMPHOTROPHIC VIRUS TYPE 1 UVEITIS; MOUTH ULCER; NECROTIZING RETINITIS; ONSET AGE; OPHTHALMOSCOPY; OPTIC NERVE ATROPHY; OPTIC NERVE DISEASE; POST STREPTOCOCCAL UVEITIS; POSTSURGICAL ENDOPHTHALMITIS; PRIMARY INTRAOCULAR LYMPHOMA; RECURRENT DISEASE; RETINA DISEASE; RETINA TEAR; RETINA VASCULITIS; RETINITIS; RETINITIS PIGMENTOSA; RETINOBLASTOMA; RETROBULBAR OPTIC NEUROPATHY; SARCOIDOSIS; SLIT LAMP; SYNCHYSIS SCINTILLANS; SYPHILIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TOXOCARIASIS; TOXOPLASMOSIS; TUBERCULOSIS; UVEITIS; VARICELLA ZOSTER VIRUS; VITRITIS;

BEHCET SYNDROME; DIAGNOSIS, DIFFERENTIAL; HUMANS; PANUVEITIS;

EID: 84884924176     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.3109/09273948.2013.795228     Document Type: Article

References (106)

1. Evereklioglu C. Current concepts in the etiology and treatment of Behçet disease. Surv Ophthalmol. 2005;50: 297-350.
2. Mason RM, Barnes CG. Behcet?s syndrome with arthritis. Ann Rheum Dis. 1969;28:73-78.
3. O?Duffy JD, Goldstein NP: Neurologic involvement in seven patients with Behçet?s disease. Am J Med. 1976;61: 170-178.
4. Nishiyama M, Nakae K, Yukawa S, et al. A study of comparison between the nationwide epidemiological survey in 1991 and previous surveys on Behçet?s disease in Japan. Environ Health Prev Med. 1999;4:130-134.
5. Criteria for diagnosis of Behçet?s disease. International Study Group for Behçet?s Disease. Lancet. 1990;335:1078-1080.
6. Kurokawa MS, Suzuki N. Behcet?s disease. Clin Exp Med. 2004;3:10-20.
7. Davatchi F. Diagnosis/classification criteria for Behcet?s disease. Patholog Res Int. 2012;2012:607921.
8. Ideguchi H, Suda A, Takeno M, et al. Behçet disease:evolution of clinical manifestations. Medicine (Baltimore). 2011; 90:125-132.
9. Alpsoy E, Donmez L, Onder M, et al. Clinical features and natural course of Behçet?s disease in 661 cases: a multicentre study. Br J Dermatol. 2007;157:901-906.
10. Yazici H. Diagnostic versus classification criteria-a continuum. Bull NYU Hosp Jt Dis. 2009;67:206-208.
11. Mishima S, Masuda K, Izawa Y, et al. The eighth Frederick H. Verhoeff Lecture, presented by Saiichi Mishima, MD. Behçet?s disease in Japan: ophthalmologic aspects. Trans Am Ophthalmol Soc. 1979;77:225-279.
12. Deuter CM, Ko tter I, Wallace GR, et al. Behçet?s disease: ocular effects and treatment. Prog Retin Eye Res. 2008;27: 111-136.
13. Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, et al. Uveitis in Behçet disease: an analysis of 880 patients. Am J Ophthalmol. 2004;138:373-380.
14. Khairallah M, Attia S, Yahia SB, et al. Pattern of uveitis in Behçet?s disease in a referral center in Tunisia, North Africa. Int Ophthalmol. 2009;29:135-141.
15. Yang P, Fang W, Meng Q, et al. Clinical features of Chinese patients with Behçet?s disease. Ophthalmology. 2008;115:312-318.
16. Kaçmaz RO, Kempen JH, Newcomb C, et al. Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Group. Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity. Am J Ophthalmol. 2008;146:828-836.
17. Sachdev N, Kapali N, Singh R, et al. Spectrum of Behçet?s disease in the Indian population. Int Ophthalmol. 2009;29: 495-501.
18. Kitaichi N, Miyazaki A, Iwata D, et al. Ocular features of Behçet?s disease: an international collaborative study. Br J Ophthalmol. 2007;91:1578-1582.
19. Behçet H. U ber rezidivierende aphthose durch ein Virus verursachte Geschwu re am Mund, am Auge und an den Genitalien. Dermatol Wochenschr. 1937;105:1152-1157.
20. Zaidi AA, Ying GS, Daniel E, et al. Hypopyon in patients with uveitis. Ophthalmology. 2010;117:366-372.
21. Ramsay A, Lightman S. Hypopyon uveitis. Surv Ophthalmol. 2001;46:1-18.
22. Tugal-Tutkun I, Cingu K, Kir N, et al. Use of laser flare-cell photometry to quantify intraocular inflammation in patients with Behçet uveitis. Graefes Arch Clin Exp Ophthalmol. 2008;246:1169-1177.
23. Yang P, Fang W, Huang X, et al. Alterations of aqueous flare and cells detected by laser flare-cell photometry in patients with Behçet?s disease. Int Ophthalmol. 2010:30: 485-489.
24. Chang JH, McCluskey PJ, Wakefield D. Acute anterior uveitis and HLA-B27. Surv Ophthalmol. 2005;50: 364-388.
25. Bernasconi O, Papadia M, Herbort CP. Sensitivity of laser flare photometry compared to slit-lamp cell evaluation in monitoring anterior chamber inflammation in uveitis. Int Ophthalmol. 2010;30:495-500.
26. Loh AR, Acharya NR. Incidence rates and risk factors for ocular complications and vision loss in HLA-B27-associated uveitis. Am J Ophthalmol. 2010;150:534-542.
27. Levine JS, Burakoff R. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2011;7:235-241.
28. Taylor SR, McCluskey P, Lightman S. The ocular manifestations of inflammatory bowel disease. Curr Opin Ophthalmol. 2006;17:538-544.
29. Lee SK, Kim BK, Kim TI, et al. Differential diagnosis of intestinal Behçet?s disease and Crohn?s disease by colonoscopic findings. Endoscopy. 2009;41:9-16.
30. Jap A, Chee SP. Viral anterior uveitis. Curr Opin Ophthalmol. 2011;22:483-488.
31. Tugal-Tutkun I, Otu k-Yasar B, Altinkurt E. Clinical features and prognosis of herpetic anterior uveitis: a retrospective study of 111 cases. Int Ophthalmol. 2010;30:559-565.
32. Biswas J, Samanta TK, Madhavan HN, et al. Acute panuveitis with haemorrhagic hypopyon as a presenting feature of acquired immunodeficiency syndrome (AIDS). Indian J Ophthalmol. 2000;48:311-312.
33. Park UC, Kim SJ, Yu HG. Cytomegalovirus endotheliitis after fluocinolone acetonide (Retisert) implant in a patient with Behçet uveitis. Ocul Immunol Inflamm. 2011;19:282-283.
34. Vitale AT, Zierhut M, Foster CS. Intermediate uveitis. In: Foster CS, Vitale AT, eds. Diagnosis and Treatment of Uveitis. Philadelphia: WB Saunders; 2002:844-857.
35. Biswas J, Sudharshan S. Intermediate uveitis. In: Gupta A, Gupta V, Herbort CP, Khairallah M, eds. Uveitis Text and Imaging. New Delhi: Jaypee Brothers Medical Publishers; 2009:348-362.
36. Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, et al. Neovascularization of the optic disc in Behçet?s disease. Jpn J Ophthalmol. 2006;50:256-265.
37. Fu EX, Geraets RL, Dodds EM, et al. Superficial retinal precipitates in patients with syphilitic retinitis. Retina. 2010;30:1135-1143.
38. Vasconcelos-Santos DV, Dodds EM, Oréfice F. Review for disease of the year: differential diagnosis of ocular toxoplasmosis. Ocul Immunol Inflamm. 2011;19:171-179.
39. Zein G, Berta A, Foster CS. Multiple sclerosis-associated uveitis. Ocul Immunol Inflamm. 2004;12:137-142.
40. Edwards LJ, Dua H, Constantinescu CS. Symptomatic uveitis and multiple sclerosis. Neuroophthalmology. 2008;32: 49-54.
41. Towler HMA, Lightman S. Symptomatic intraocular inflammation in multiple sclerosis. Clin Exp Ophthalmol. 2000;28:97-102.
42. Porter R. Uveitis in association with multiple sclerosis. Br J Ophthalmol. 1972;56:478-481.
43. Prieto JF, Dios E, Gutierrez JM, et al. Pars planitis: epidemiology, treatment, and association with multiple sclerosis. Ocul Immunol Inflamm. 2001;9:93-102.
44. Bachman DM, Rosenthal AR, Beckingsale AB. Granulomatous uveitis in neurological disease. Br J Ophthalmol. 1985;69:192-196.
45. Lim JI, Tessler HH, Goodwin JA. Anterior granulomatous uveitis in patients with multiple sclerosis. Ophthalmology. 1991;98:142-145.
46. Acar MA, Birch MK, Abbott R, et al. Chronic granulomatous anterior uveitis associated with multiple sclerosis. Graefes Arch Clin Exp Ophthalmol. 1993;231:166-168.
47. Sergott RC. Historical perspective and future prospective for retinal nerve fiber loss in optic neuritis and multiple sclerosis. Int Ophthalmol Clin. 2007;47:15-24.
48. Sakai RE, Feller DJ, Galetta KM, et al. Vision in multiple sclerosis: the story, structure-function correlations, and models for neuroprotection. J Neuroophthalmol. 2011; 31:362-373.
49. Boskovich SA, Lowder CY, Meisler DM, et al. Systemic diseases associated with intermediate uveitis. Clev Clin J Med. 1993;60:460-465.
50. Vidovic-Valentincic N, Kraut A, Hawlina M, et al. Intermediate uveitis: long-term course and visual outcome. Br J Ophthalmol. 2009;93:477-80.
51. Khairallah M, Hmidi K, Attia S, et al. Clinical characteristics of intermediate uveitis in Tunisian patients. Int Ophthalmol. 2010;30:531-537.
52. Soheilian M, Heidari K, Yazdani S, et al. Patterns of uveitis in a tertiary eye care center in Iran. Ocul Immunol Inflamm. 2004;12:297-310.
53. Kazokoglu H, Onal S, Tugal-Tutkun I, et al. Demographic and clinical features of uveitis in tertiary centers in Turkey. Ophthalmic Epidemiol. 2008;15:285-293.
54. Herbort CP, Rao NA, Mochizuki M, et al. International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop on Ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm. 2009;17:160-169.
55. Espinosa G, Font J, Tassies D, et al. Vascular involvement in Behçet?s disease: relation with thrombophilic factors, coagulation activation and thrombomodulin. Am J Med. 2002;112:37-43.
56. Haznedaroglu IC, Ozcebe O, Celik I, et al. Haemostatic markers of procoagulant imbalance in Behçet?s disease. Eur J Haematol. 1996;57:107-108.
57. Gul A, Aslantas AB, Tekinay T, et al. Procoagulant mutations and venous thrombosis in Behçet?s disease. Rheumatology. 1999;38:1298-1299.
58. Verity DH, Vaughan RW, Madanat W, et al. Factor V Leiden mutation is associated with ocular involvement in Behçet?s disease. Am J Ophthalmol. 1999;128:352-356.
59. Er H, Everekioglu C, Cumurcu T, et al. Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behçet?s disease. Br J Ophthalmol. 2002; 86:653-657.
60. Hong SN, Park JC, Yoon NS, et al. Carotid artery intimamedia thickness in Behcet?s disease patients without significant cardiovascular involvement. Korean J Intern Med. 2008;23:87-93.
61. Tugal Tutkun I. Behçet?s disease. In: Gupta A, Gupta V, Herbort CP, Khairallah M, eds. Uveitis Text and Imaging. New Delhi: Jaypee Brothers Medical Publishers; 2009:397-413.
62. Ramachandran R, Hughes E, Larkin G, et al. Secondary frosted branch angiitis in neuro-Behcet?s disease with serous macular detachment. Pediatr Int. 2011;53:285-286.
63. Jackson TE, Pathak S, Doran RM. Behçet?s disease presenting with frosted branch angiitis. Ocul Immunol Inflamm. 2011;19:65-66.
64. Al-Mujaini A, Wali UK. Frosted branch angiitis, neuroretinitis as initial ocular manifestation in Behçet?s disease. Indian J Ophthalmol. 2011;59:240-241.
65. Tugal Tutkun I. Behçet?s uveitis. Middle East Afr J Ophthalmol. 2009;16:219-224.
66. Atmaca LS. Fundus changes associated with Behçet?s disease. Grafe?s Arch Clin Exp Ophthalmol. 1989;227:340-344.
67. Gupta A, Bansal R, Gupta V, et al. Ocular signs predictive of tubercular uveitis. Am J Ophthalmol. 2010 Apr;149: 562-570.
68. Gupta A, Gupta V, Arora S, et al. PCR positive tubercular retinal vasculitis: clinical characteristics & management. Retina. 2001:21:435-444.
69. Biswas J, Therese L, Madhavan HN. Use of polymerase chain reaction in detection of Mycobacterium tuberculosis complex DNA from vitreous samples of Eales? disease. Br J Ophthalmol. 1999;83:994.
70. Margo CE, Hamed AM. Ocular syphilis. Surv Ophthalmol. 1992;37:203-220.
71. Morse PH. Retinal venous sheathing and neovascularization in disseminated sclerosis. Ann Ophthalmol. 1975;7: 949-52.
72. Lanham JG, Barrie T, Kohner EM, et al. SLE retinopathy: evaluation by fluorescein angiography. Ann Rheum Dis. 1982;41:473-478.
73. Jabs DA, Fine SL Hochberg MC, et al. Severe retinal venoocclusive disease in systemic lupus erythematosus. Arch Ophthalmol. 1986;104:558-563.
74. Chang TS, Aylward W, Davis JL, et al. Idiopathic retinal vasculitis aneurysms and neuroretinitis. Ophthalmology. 1995;102:1089-1097.
75. Pulido JS, Goeken JA, Nerad JA, et al. Ocular manifestations of patients with circulating anti neutrophil cytoplasmic antibodies. Arch Ophthalmol. 1990; 108:845-850.
76. Iida T, Spaide RF, Kantor J. Retinal and choroidal arterial occlusion in Wegener?s granulomatosis. Am J Ophthalmol. 2002;133:151-152.
77. Morgan CM, Foster CS, Gragoudas ES. Retinal vasculitis in polyarteritis nodosa. Retina. 1986;6:205-209.
78. Akova YA, Jabbur NS, Foster CS. Ocular presentation of polyarteritis nodosa: clinical course and management with steroid and cytotoxic therapy. Ophthalmology. 1993;100: 1775-1781.
79. Blumenkanz MZ, Kaplan HJ, Clarkson JG, et al. Acute multifocal hemorrhagic retinal vasculitis. Ophthalmology. 1988;95:1663-1672.
80. Okada AA. Behçet?s disease: general concepts and recent advances. Curr Opin Ophthalmol. 2006;17:551-556.
81. Dominguez LN, Irvine AR. Fundus changes in Behcet?s disease. Trans Am Ophthalmol Soc. 1997;95:367-382.
82. Klaeger AJ, Herbort CP. Cotton wool spots as possible indicators of retinal vascular pathology in ocular lyme borreliosis. Int Ophthalmol. 2010;30:599-602.
83. McLeod D. Why cotton wool spots should not be regarded as retinal nerve fibre layer infarcts. Br J Ophthalmol. 2005; 89:229-237.
84. Kozak I, Bartsch DU, Cheng L, et al. Hyperreflective sign in resolved cotton wool spots using high-resolution optical coherence tomography and optical coherence tomography ophthalmoscopy. Ophthalmology. 2007;114:537-543.
85. Gomez ML, Mojana F, Bartsch DU, et al. Imaging of longterm retinal damage after resolved cotton wool spots. Ophthalmology. 2009;116:2407-2414.
86. Delair E, Latkany P, Noble AG, et al. Clinical manifestations of ocular toxoplasmosis. Ocul Immunol Inflamm. 2011;19:91-102.
87. Tugal-Tutkun I, Corum I, O tuk B, et al. Active ocular toxoplasmosis in Turkish patients: a report on 109 cases. Int Ophthalmol. 2005;26:221-228.
88. Auer C, Bernasconi O, Herbort CP. Indocyanine green angioraphy features in toxoplasmic retinochoroiditis. Retina. 1999;19:22-29.
89. Vasconcelos-Santos DV, Dodds EM, Orefice F. Review for disease of the year: differential diagnosis of ocular toxoplasmosis. Ocul Immunol Inflamm. 2011;19:171-179.
90. Khairallah M, Ladjimi A, Chakroun M, et al. Posterior segment manifestations of Rickettsia conorii infection. Ophthalmology. 2004;111:529-534.
91. Ormerod LD, Dailey JP. Ocular manifestations of catscratch disease. Curr Opin Ophthalmol. 1999;10:209-216.
92. Curi ALL, Machado D, Heringer G, et al. Cat-scratch disease: ocular manifestations and visual outcome. Int Ophthalmol. 2010;30:553-558.
93. Usui Y, Goto H. Overview and diagnosis of acute retinal necrosis syndrome. Semin Ophthalmol. 2008;23:275-283.
94. Dhillon B. The management of cytomegalovirus retinitis in AIDS. Br J Ophthalmol. 1994;78:66-69.
95. Ufret-Vincenty RL, Singh RP, Lowder C, et al. Cytomegalovirus retinitis after fluocinolone acetonide (Retiserttm) implant. Am J Ophthalmol. 2007;143:334-335.
96. Tugal-Tutkun I, Araz B, Cagatay A. CMV retinitis after intravitreal triamcinolone acetonide injection in a patient with Behçet?s uveitis. Int Ophthalmol. 2010;30:591-593.
97. Gass JD, Braunstein RA, Chenoweth RG. Acute syphilitic posterior placoid chorioretinitis. Ophthalmology. 1990;97: 1288-1297.
98. Teasley LA, Foster CS. Syphilis: an ophthalmologic update. Int Ophthalmol Clin. 2007;47:133-144.
99. Rajagopal R, Harbour JW. Diagnostic testing and treatment choices in primary vitreoretinal lymphoma. Retina. 2011;31:435-440.
100. Chan CC, Wallace DJ. Intraocular lymphoma: update on diagnosis and management. Cancer Control. 2004;11:285-295.
101. Fardeau C, Lee CP, Merle-Béral H, et al. Retinal fluorescein, indocyanine green angiography, and optic coherence tomography in non-Hodgkin primary intraocular lymphoma. Am J Ophthalmol. 2009;147:886-894.
102. Cetin EN, Yaylali V, Yildirim C. Isolated optic neuropathy in a case of Behçet?s disease. Int Ophthalmol. 2011;31:153-155.
103. Yalçindag N, Yilmaz N, Tekeli O, et al. Acute optic neuropathy in Behçet disease. Eur J Ophthalmol. 2004;14: 578-580.
104. Lim JW, Kang SH. A case of Behçet's disease complicated by bilateral posterior ischemic optic neuropathy. Int Ophthalmol. 2011;31:157-160.
105. Hamel C. Retinitis pigmentosa. Orphanet J Rare Dis. 2006; 1:40.
106. Wakefield D, Cunningham ET Jr, Tugal-Tutkun I, et al. Controversies in Behçet disease. Ocul Immunol Inflamm. 2012;20:6-11.